Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementation

Abstract Background Research waste is estimated to be very common, but assessments of its prevalence and scope are rare. As an example, we assessed research waste in clinical research on calcium intake (assessing study design and endpoint type) and vitamin D supplementation (assessing endpoint type)...

Full description

Bibliographic Details
Main Authors: Mark J. Bolland, Alison Avenell, Andrew Grey
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12874-018-0556-0
id doaj-4633f6cfeb424c32ab3c910f21f12b23
record_format Article
spelling doaj-4633f6cfeb424c32ab3c910f21f12b232020-11-25T02:14:53ZengBMCBMC Medical Research Methodology1471-22882018-10-0118111010.1186/s12874-018-0556-0Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementationMark J. Bolland0Alison Avenell1Andrew Grey2Bone and Joint Research Group, Department of Medicine, University of AucklandHealth Services Research Unit, University of AberdeenBone and Joint Research Group, Department of Medicine, University of AucklandAbstract Background Research waste is estimated to be very common, but assessments of its prevalence and scope are rare. As an example, we assessed research waste in clinical research on calcium intake (assessing study design and endpoint type) and vitamin D supplementation (assessing endpoint type). Methods We examined 404 randomised controlled trials (RCTs) and observational studies of calcium intake (diet or supplements) and bone mineral density (BMD) or fracture, and 547 RCTs of vitamin D supplements, and assessed the proportion of studies that used surrogate or clinical endpoints. For studies with BMD or fracture as an endpoint, we estimated when the ‘tipping’ point occurred indicating the need for RCTs with fracture as an endpoint (based on cumulative meta-analyses of BMD RCTs, and chronological review of observational studies), and whether each study published at least 5y after the tipping point was novel, added new clinical knowledge or was research waste. Results Observational studies of calcium intake and BMD or fracture outnumbered RCTs by 3.3–4.5 times. For both calcium intake and vitamin D supplements, studies using surrogate endpoints outnumbered studies using clinical endpoints by 1.6–3 times. Of 41 RCT publications of calcium intake and BMD or fracture published at least 5y after the tipping point in 1994, we considered that 19 (46%) lacked novelty, another 13 (32%) added no new clinical knowledge, and 30 (73%) were research waste. Of 204 observational study publications of calcium intake and BMD or fracture, 197 (96%) lacked novelty, another 5 (2%) added no new clinical knowledge, and 202 (99%) were research waste. Of 39 RCTs of vitamin D supplementation and BMD or fracture published at least 5y after the tipping point in 1999, 14 (36%) lacked novelty, another 13 (33%) added no new clinical knowledge, and 27 (69%) were research waste. Conclusions A high proportion of studies of calcium intake since 2000 (95%) and trials of vitamin D supplements since 2005 (69%) on BMD or fracture represent research waste.http://link.springer.com/article/10.1186/s12874-018-0556-0Calcium intakeVitamin DResearch wasteObservational studiesRandomized controlled trialsSurrogate endpoints
collection DOAJ
language English
format Article
sources DOAJ
author Mark J. Bolland
Alison Avenell
Andrew Grey
spellingShingle Mark J. Bolland
Alison Avenell
Andrew Grey
Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementation
BMC Medical Research Methodology
Calcium intake
Vitamin D
Research waste
Observational studies
Randomized controlled trials
Surrogate endpoints
author_facet Mark J. Bolland
Alison Avenell
Andrew Grey
author_sort Mark J. Bolland
title Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementation
title_short Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementation
title_full Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementation
title_fullStr Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementation
title_full_unstemmed Assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin D supplementation
title_sort assessment of research waste part 1: an exemplar from examining study design, surrogate and clinical endpoints in studies of calcium intake and vitamin d supplementation
publisher BMC
series BMC Medical Research Methodology
issn 1471-2288
publishDate 2018-10-01
description Abstract Background Research waste is estimated to be very common, but assessments of its prevalence and scope are rare. As an example, we assessed research waste in clinical research on calcium intake (assessing study design and endpoint type) and vitamin D supplementation (assessing endpoint type). Methods We examined 404 randomised controlled trials (RCTs) and observational studies of calcium intake (diet or supplements) and bone mineral density (BMD) or fracture, and 547 RCTs of vitamin D supplements, and assessed the proportion of studies that used surrogate or clinical endpoints. For studies with BMD or fracture as an endpoint, we estimated when the ‘tipping’ point occurred indicating the need for RCTs with fracture as an endpoint (based on cumulative meta-analyses of BMD RCTs, and chronological review of observational studies), and whether each study published at least 5y after the tipping point was novel, added new clinical knowledge or was research waste. Results Observational studies of calcium intake and BMD or fracture outnumbered RCTs by 3.3–4.5 times. For both calcium intake and vitamin D supplements, studies using surrogate endpoints outnumbered studies using clinical endpoints by 1.6–3 times. Of 41 RCT publications of calcium intake and BMD or fracture published at least 5y after the tipping point in 1994, we considered that 19 (46%) lacked novelty, another 13 (32%) added no new clinical knowledge, and 30 (73%) were research waste. Of 204 observational study publications of calcium intake and BMD or fracture, 197 (96%) lacked novelty, another 5 (2%) added no new clinical knowledge, and 202 (99%) were research waste. Of 39 RCTs of vitamin D supplementation and BMD or fracture published at least 5y after the tipping point in 1999, 14 (36%) lacked novelty, another 13 (33%) added no new clinical knowledge, and 27 (69%) were research waste. Conclusions A high proportion of studies of calcium intake since 2000 (95%) and trials of vitamin D supplements since 2005 (69%) on BMD or fracture represent research waste.
topic Calcium intake
Vitamin D
Research waste
Observational studies
Randomized controlled trials
Surrogate endpoints
url http://link.springer.com/article/10.1186/s12874-018-0556-0
work_keys_str_mv AT markjbolland assessmentofresearchwastepart1anexemplarfromexaminingstudydesignsurrogateandclinicalendpointsinstudiesofcalciumintakeandvitamindsupplementation
AT alisonavenell assessmentofresearchwastepart1anexemplarfromexaminingstudydesignsurrogateandclinicalendpointsinstudiesofcalciumintakeandvitamindsupplementation
AT andrewgrey assessmentofresearchwastepart1anexemplarfromexaminingstudydesignsurrogateandclinicalendpointsinstudiesofcalciumintakeandvitamindsupplementation
_version_ 1724899078254362624